These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38701382)

  • 1. Plasma Kidney Injury Molecule-1 for Preoperative Prediction of Renal Cell Carcinoma Versus Benign Renal Masses, and Association With Clinical Outcomes.
    Xu W; Gaborieau V; Niman SM; Mukeria A; Liu X; Maremanda KP; Takakura A; Zaridze D; Freedman ML; Xie W; McDermott DF; Choueiri TK; Catalano PJ; Sabbisetti V; Bonventre JV; Pierorazio PM; Singla N; Brennan P; Bhatt RS
    J Clin Oncol; 2024 Aug; 42(22):2691-2701. PubMed ID: 38701382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma.
    Gatto F; Blum KA; Hosseini SS; Ghanaat M; Kashan M; Maccari F; Galeotti F; Hsieh JJ; Volpi N; Hakimi AA; Nielsen J
    Eur Urol Oncol; 2018 Oct; 1(5):364-377. PubMed ID: 31158075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIM-1 as a Blood-Based Marker for Early Detection of Kidney Cancer: A Prospective Nested Case-Control Study.
    Scelo G; Muller DC; Riboli E; Johansson M; Cross AJ; Vineis P; Tsilidis KK; Brennan P; Boeing H; Peeters PHM; Vermeulen RCH; Overvad K; Bueno-de-Mesquita HB; Severi G; Perduca V; Kvaskoff M; Trichopoulou A; La Vecchia C; Karakatsani A; Palli D; Sieri S; Panico S; Weiderpass E; Sandanger TM; Nøst TH; Agudo A; Quirós JR; Rodríguez-Barranco M; Chirlaque MD; Key TJ; Khanna P; Bonventre JV; Sabbisetti VS; Bhatt RS
    Clin Cancer Res; 2018 Nov; 24(22):5594-5601. PubMed ID: 30037816
    [No Abstract]   [Full Text] [Related]  

  • 4. Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma.
    Dalpiaz O; Pichler M; Mrsic E; Reitz D; Krieger D; Venturino L; Bezan A; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC
    J Clin Pathol; 2015 Jul; 68(7):547-51. PubMed ID: 25862811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study.
    Morrissey JJ; Mellnick VM; Luo J; Siegel MJ; Figenshau RS; Bhayani S; Kharasch ED
    JAMA Oncol; 2015 May; 1(2):204-12. PubMed ID: 26181025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External validation of the RENAL nephrometry score nomogram for predicting high-grade renal cell carcinoma in solid, enhancing, and small renal masses.
    Koo KC; Yoo H; Shin TY; Kim J; Choi YD; Rha KH; Ham WS
    World J Urol; 2014 Feb; 32(1):249-55. PubMed ID: 24013182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive Nephrectomy.
    DiNatale RG; Xie W; Becerra MF; Silagy AW; Attalla K; Sanchez A; Mano R; Marcon J; Blum KA; Benfante NE; Voss MH; Motzer RJ; Coleman J; Choueiri TK; Reznik E; Russo P; Heng DYC; Hakimi AA
    Eur Urol Oncol; 2020 Feb; 3(1):47-56. PubMed ID: 31735646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the prognosis of patients with renal cell carcinoma based on the systemic immune inflammation index and prognostic nutritional index.
    Ma W; Liu W; Dong Y; Zhang J; Hao L; Xia T; Wang X; Han C
    Sci Rep; 2024 Oct; 14(1):25045. PubMed ID: 39443568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An In-vivo Prospective Study of the Diagnostic Yield and Accuracy of Optical Biopsy Compared with Conventional Renal Mass Biopsy for the Diagnosis of Renal Cell Carcinoma: The Interim Analysis.
    Buijs M; Wagstaff PGK; de Bruin DM; Zondervan PJ; Savci-Heijink CD; van Delden OM; van Leeuwen TG; van Moorselaar RJA; de la Rosette JJMCH; Laguna Pes MP
    Eur Urol Focus; 2018 Dec; 4(6):978-985. PubMed ID: 29079496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment.
    Bhindi B; Thompson RH; Lohse CM; Mason RJ; Frank I; Costello BA; Potretzke AM; Hartman RP; Potretzke TA; Boorjian SA; Cheville JC; Leibovich BC
    Eur Urol; 2018 Oct; 74(4):489-497. PubMed ID: 30017400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients.
    Pichler M; Hutterer GC; Stojakovic T; Mannweiler S; Pummer K; Zigeuner R
    Br J Cancer; 2013 Sep; 109(5):1123-9. PubMed ID: 23922109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study.
    Lee H; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
    BJU Int; 2017 Feb; 119(2):261-267. PubMed ID: 27226065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine aquaporin 1 and perilipin 2 differentiate renal carcinomas from other imaged renal masses and bladder and prostate cancer.
    Morrissey JJ; Mobley J; Figenshau RS; Vetter J; Bhayani S; Kharasch ED
    Mayo Clin Proc; 2015 Jan; 90(1):35-42. PubMed ID: 25572193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical T1/2 renal cell carcinoma: multiparametric dynamic contrast-enhanced MRI features-based model for the prediction of individual adverse pathology.
    Wang K; Guo B; Yao Z; Li G
    World J Surg Oncol; 2024 Jun; 22(1):145. PubMed ID: 38822338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of renal mass aggressiveness using clinical and radiographic features: a global, multicentre prospective study.
    Golan S; Eggener S; Subotic S; Barret E; Cormio L; Naito S; Tefekli A; Pilar Laguna Pes M
    BJU Int; 2016 Jun; 117(6):914-22. PubMed ID: 26389787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative apolipoprotein B/A1 ratio is an independent prognostic factor in metastatic renal cell carcinoma.
    Zhang F; Xie Y; Ma X; Gu L; Li H; Li X; Guo G; Zhang X
    Urol Oncol; 2019 Mar; 37(3):184.e9-184.e17. PubMed ID: 30509867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in papillary renal cell carcinoma patients after receiving curative surgery based on a retrospective cohort.
    Zhang Z; Yu Y; Zheng J; Zhang M; Niu H
    BMC Urol; 2021 Mar; 21(1):43. PubMed ID: 33752642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of extensive necrosis in renal cell carcinoma.
    Collins J; Epstein JI
    Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of blood oxygenation level-dependent (BOLD) MR imaging in differentiation of renal solid mass and grading of renal cell carcinoma (RCC): analysis based on the largest cross-sectional area versus the entire whole tumour.
    Wu GY; Suo ST; Lu Q; Zhang J; Zhu WQ; Xu JR
    PLoS One; 2015; 10(4):e0123431. PubMed ID: 25875306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Nomogram Including Sarcopenia for Predicting Progression-Free Survival in Patients with Localized Papillary Renal Cell Carcinoma: A Retrospective Cohort Study.
    Su W; Wu Y; Liao S; Zhang Z; Zhang Y; Ou W; Yu J; Xiang F; Luo C; Zheng F
    Ann Surg Oncol; 2024 Sep; 31(9):5815-5826. PubMed ID: 38954088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.